Literature DB >> 9669585

Influence of patient height and weight and type of stress on myocardial count density during SPECT imaging with thallium-201 and technetium 99m-sestamibi.

M K O'Connor1, E Bothun, R J Gibbons.   

Abstract

BACKGROUND: The aim of this study was to determine the variability in myocardial activity with 99mTc-labeled sestamibi and 201Tl tomographic imaging, and to correlate this variability with patient anthropometric data and type of stress. METHODS AND
RESULTS: Conventional tomographic acquisition (all-purpose collimator, 30 views, 40 sec/view) was performed in 249 patients (155 with 99mTc-sestamibi, 84 with 201Tl). Normal myocardium was identified in three short-axis tomographic slices between the base and mid-ventricle. To exclude abnormal myocardium, all myocardial activity below an 85% threshold of peak counts was excluded. The average counts per pixel in the remaining myocardium was determined. All data were normalized to a collimator sensitivity of 8.1 counts/min/kBq and corrected for decay. Myocardial count densities in both 201Tl and 99mTc-sestamibi studies exhibited a high degree of variability and varied by factors of 3 to 4 and 2.5 to 3 respectively, between the 10th and 90th percentile of count densities. All 99mTc-sestamibi studies showed an inverse correlation (R approximately 0.7) between myocardial count density and patient weight. For stress 201Tl studies in male patients, a similar inverse correlation (R = 0.63) was found between patient weight and myocardial count density. No correlation was found for female patients. For rest 99mTc-sestamibi studies, the average myocardial count density was 1245 +/- 297 counts/pixel for a 1.11 GBq (30 mCi) injection. This was similar with pharmacologic stress (1224 +/- 297 counts/pixel per 1.11 GBq (30 mCi), but significantly higher with exercise (1569 +/- 363 counts/pixel per 1.11 GBq (30 mCi) (p < 0.005). 201Tl studies averaged 327 +/- 97 counts/pixel (111 MBq [3 mCi] injection) with exercise and 374 +/- 145 counts/pixel/111 MBq (3 mCi) with pharmacologic stress (p = NS). Redistribution studies after exercise/pharmacologic stress (with a 37 MBq [1 mCi] reinjection) averaged 267 +/- 83 counts/pixel (148 MBq [3+1 mCi]).
CONCLUSIONS: Measured count densities in the myocardium demonstrate a high degree of variability that is only weakly correlated with patient anthropometric data. Nevertheless, knowledge of the mean values of myocardial activity as a function of administered dose may be useful in the optimization of rapid imaging procedures for 99mTc-based perfusion agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669585     DOI: 10.1016/s1071-3581(98)90132-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  17 in total

Review 1.  Single-photon emission computed tomographic thallium imaging with adenosine, dipyridamole, and exercise.

Authors:  A S Iskandrian
Journal:  Am Heart J       Date:  1991-07       Impact factor: 4.749

2.  Fast stress and rest acquisitions for technetium-99m-sestamibi separate-day SPECT.

Authors:  E G DePuey; K J Nichols; J S Slowikowski; W J Scarpa; C J Smith; S Melancon; S Newman
Journal:  J Nucl Med       Date:  1995-04       Impact factor: 10.057

3.  Pharmacokinetics of thallium-201 in normal individuals after routine myocardial scintigraphy.

Authors:  W Krahwinkel; H Herzog; L E Feinendegen
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

Review 4.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

5.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.

Authors:  R J Gibbons; M S Verani; T Behrenbeck; P A Pellikka; M K O'Connor; J J Mahmarian; J H Chesebro; F J Wackers
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi).

Authors:  M K O'Connor; T Hammell; R J Gibbons
Journal:  Eur J Nucl Med       Date:  1990

7.  Haemodynamic and metabolic effects of infused adenosine in man.

Authors:  A Edlund; A Sollevi; B Linde
Journal:  Clin Sci (Lond)       Date:  1990-08       Impact factor: 6.124

8.  Organ distribution of thallium-201 during intravenous adenosine infusion: comparison with exercise.

Authors:  Y Takeishi; S Abe; J Chiba; A Komatani; Y Nakagawa; H Tomoike
Journal:  Am Heart J       Date:  1994-05       Impact factor: 4.749

9.  Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers.

Authors:  S Borges-Neto; R E Coleman; R H Jones
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

Review 10.  Comparison of thallium-201 and technetium-99m methoxyisobutyl isonitrile.

Authors:  F J Wackers
Journal:  Am J Cardiol       Date:  1992-11-05       Impact factor: 2.778

View more
  3 in total

1.  Stress-only imaging in patients with prior SPECT MPI: a simulation study.

Authors:  John J Ryan; Rupa Mehta; Thejasvi Thiruvoipati; R Parker Ward; Kim Allan Williams
Journal:  J Nucl Cardiol       Date:  2012-01-19       Impact factor: 5.952

2.  Factors affecting the myocardial activity acquired during exercise SPECT with a high-sensitivity cardiac CZT camera as compared with conventional Anger camera.

Authors:  Antoine Verger; Laetitia Imbert; Yalcine Yagdigul; Renaud Fay; Wassila Djaballah; François Rouzet; Nicolas Fourquet; Sylvain Poussier; Véronique Roch; Dominique Le Guludec; Gilles Karcher; Pierre-Yves Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-08       Impact factor: 9.236

3.  Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using conventional SPECT.

Authors:  J D van Dijk; P L Jager; J P Ottervanger; J de Boer; A H J Oostdijk; E M Engbers; C H Slump; S Knollema; J A van Dalen
Journal:  J Nucl Cardiol       Date:  2015-09-09       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.